Clinical trial
Optimizing a Scalable Intervention to Maximize Guideline-recommended Diabetes Testing After GDM
NCT05752292 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing a Scalable Intervention to Maximize Guideline-recommended Diabetes Testing After GDM
- Lead sponsor
- University of California, Davis
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- April 13, 2023
- Completion date
- December 31, 2026
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.